These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28438049)

  • 1. Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes.
    Argikar UA; Dumouchel JL; Dunne CE; Bushee AJ
    Drug Metab Rev; 2017 Aug; 49(3):372-394. PubMed ID: 28438049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
    Niwa T; Murayama N; Yamazaki H
    Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics.
    Foti RS; Dalvie DK
    Drug Metab Dispos; 2016 Aug; 44(8):1229-45. PubMed ID: 27298339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.
    Nakano M; Lockhart CM; Kelly EJ; Rettie AE
    Drug Metab Rev; 2014 Aug; 46(3):247-60. PubMed ID: 24856391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s.
    Worsch A; Eggimann FK; Girhard M; von Bühler CJ; Tieves F; Czaja R; Vogel A; Grumaz C; Sohn K; Lütz S; Kittelmann M; Urlacher VB
    Biotechnol Bioeng; 2018 Sep; 115(9):2156-2166. PubMed ID: 29943426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P450 structures and oxidative metabolism of xenobiotics.
    Lewis DF
    Pharmacogenomics; 2003 Jul; 4(4):387-95. PubMed ID: 12831319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the world of cytochrome P450 enzymes.
    Frye RF
    Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cytochrome P450-mediated bioactivation and its toxicological relevance.
    Gan J; Ma S; Zhang D
    Drug Metab Rev; 2016 Nov; 48(4):473-501. PubMed ID: 27533622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors.
    Xu D; Huang S; Wang H; Xie W
    Drug Metab Rev; 2018 Nov; 50(4):407-414. PubMed ID: 30501435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of membrane transporters and metabolizing enzymes in ocular drug delivery.
    Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
    Curr Drug Metab; 2014; 15(7):680-93. PubMed ID: 25255873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 and xenobiotic receptor humanized mice.
    Gonzalez FJ; Yu AM
    Annu Rev Pharmacol Toxicol; 2006; 46():41-64. PubMed ID: 16402898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptomyces cytochromes P450: applications in drug metabolism.
    Lamb DC; Waterman MR; Zhao B
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets.
    Foti RS
    Drug Metab Dispos; 2023 Aug; 51(8):936-949. PubMed ID: 37041085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design.
    Rekka EA; Kourounakis PN; Pantelidou M
    Curr Top Med Chem; 2019; 19(4):276-291. PubMed ID: 30706817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Human Cell-Based Experimental Models for the Evaluation of Enteric Metabolism and Drug Interaction Potential of Drugs and Natural Products.
    Li AP
    Drug Metab Dispos; 2020 Oct; 48(10):980-992. PubMed ID: 32636209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development.
    Fukami T; Yokoi T; Nakajima M
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():405-425. PubMed ID: 34499522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
    Shimada T; Yamazaki H; Mimura M; Wakamiya N; Ueng YF; Guengerich FP; Inui Y
    Drug Metab Dispos; 1996 May; 24(5):515-22. PubMed ID: 8723730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocytes: the powerhouse of biotransformation.
    Sevior DK; Pelkonen O; Ahokas JT
    Int J Biochem Cell Biol; 2012 Feb; 44(2):257-61. PubMed ID: 22123318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.